Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CHRNB4 anticorps (C-Term)

CHRNB4 Reactivité: Humain WB Hôte: Lapin Polyclonal RB42408 unconjugated
N° du produit ABIN1881200
  • Antigène Voir toutes CHRNB4 Anticorps
    CHRNB4 (Cholinergic Receptor, Nicotinic, beta 4 (Neuronal) (CHRNB4))
    Épitope
    • 12
    • 7
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 422-450, C-Term
    Reactivité
    • 27
    • 10
    • 8
    Humain
    Hôte
    • 25
    • 2
    • 1
    Lapin
    Clonalité
    • 27
    • 1
    Polyclonal
    Conjugué
    • 11
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp CHRNB4 est non-conjugé
    Application
    • 20
    • 18
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Purification
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogène
    This CHRNB4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 422-450 amino acids from the C-terminal region of human CHRNB4.
    Clone
    RB42408
    Isotype
    Ig Fraction
    Top Product
    Discover our top product CHRNB4 Anticorps primaire
  • Indications d'application
    WB: 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Date de péremption
    6 months
  • Zhang, Kranzler, Poling, Gelernter: "Variation in the nicotinic acetylcholine receptor gene cluster CHRNA5-CHRNA3-CHRNB4 and its interaction with recent tobacco use influence cognitive flexibility." dans: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Vol. 35, Issue 11, pp. 2211-24, (2010) (PubMed).

    Amos, Gorlov, Dong, Wu, Zhang, Lu, Scheet, Greisinger, Mills, Spitz: "Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study." dans: Journal of the National Cancer Institute, Vol. 102, Issue 15, pp. 1199-205, (2010) (PubMed).

    Saccone, Schwantes-An, Wang, Grucza, Breslau, Hatsukami, Johnson, Rice, Goate, Bierut: "Multiple cholinergic nicotinic receptor genes affect nicotine dependence risk in African and European Americans." dans: Genes, brain, and behavior, Vol. 9, Issue 7, pp. 741-50, (2010) (PubMed).

    Hansen, Xiao, Rice, Bracci, Wrensch, Sison, Chang, Smirnov, Patoka, Seldin, Quesenberry, Kelsey, Wiencke: "Fine mapping of chromosome 15q25.1 lung cancer susceptibility in African-Americans." dans: Human molecular genetics, Vol. 19, Issue 18, pp. 3652-61, (2010) (PubMed).

  • Antigène
    CHRNB4 (Cholinergic Receptor, Nicotinic, beta 4 (Neuronal) (CHRNB4))
    Autre désignation
    CHRNB4 (CHRNB4 Produits)
    Synonymes
    anticorps Acrb-4, anticorps Acrb4, anticorps cholinergic receptor nicotinic beta 4 subunit, anticorps cholinergic receptor, nicotinic, beta polypeptide 4, anticorps CHRNB4, anticorps Chrnb4
    Sujet
    After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
    Poids moléculaire
    56380
    NCBI Accession
    NP_000741, NP_001243496
    UniProt
    P30926
Vous êtes ici:
Support technique